Who owns the MOLECULAR THERAPEUTICS trademark?

The MOLECULAR THERAPEUTICS trademark is owned by Molecular Therapeutics.

What class is the MOLECULAR THERAPEUTICS trademark registered in?

The MOLECULAR THERAPEUTICS trademark is registered in Class 035 (Advertising, business management & retail services).

What is the serial number for MOLECULAR THERAPEUTICS?

The USPTO serial number for MOLECULAR THERAPEUTICS is 78529025.

What is the registration number for MOLECULAR THERAPEUTICS?

MOLECULAR THERAPEUTICS is registered under USPTO registration number 3103317.

Sealvo

Home Search: MOLECULAR THERAPEUTICSMOLECULAR THERAPEUTICS #78529025

Back

Updated Oct 14, 2026·12 searches this week

View on USPTO TSDR Find similar marks

MOL

USPTO Trademark Record

ABANDONED

MOLECULAR THERAPEUTICS

SN 78529025·Reg 3103317·Filed Dec 08, 2004

Owner Molecular Therapeutics

Advertising; business management, organization and administration; office functions.

MOLECULAR THERAPEUTICS (Serial No. 78529025), Registration No. 3103317, is a abandoned US trademark filed on Dec 08, 2004 by Molecular Therapeutics. This trademark covers Class 035 (Advertising, business management & retail services).

Mark Intelligence

MOLECULAR THERAPEUTICS (Reg. #3103317) is an abandoned US trademark that was filed in 2004 but has since been abandoned. The mark covers Class 035 (Advertising, business management & retail services). Goods and services include Advertising; business management, organization and administration; office functions.. The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 08, 2004

SERIAL

78529025

REG#

3103317

REGISTERED

Jun 13, 2006

Filing Information

StatusABANDONED

Filing DateDec 08, 2004

Serial Number78529025

Registration No.3103317

Registration DateJun 13, 2006

Status DateJan 20, 2017

Published for OppositionMar 21, 2006

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlySection 8 AcceptedSection 15 Acknowledged

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Jul 01, 2001

First use in commerce: Sep 01, 2001

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Jan 20, 2017

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jun 13, 2015

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Sep 10, 2012

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Sep 10, 2012

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Sep 07, 2012

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jun 29, 2012

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

Jun 29, 2012

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 25, 2012

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS SECTION 8 & 15 RECEIVED

Jun 25, 2012

TEAS SECTION 8 & 15 RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jun 13, 2006

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 21, 2006

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Mar 01, 2006

NOTICE OF PUBLICATION

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 03, 2006

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Jan 27, 2006

ASSIGNED TO LIE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 23, 2006

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 23, 2006

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 17, 2006

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 13, 2006

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 13, 2006

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 10, 2006

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 10, 2006

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Jul 13, 2005

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jul 13, 2005

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 13, 2005

NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Dec 17, 2004

NEW APPLICATION ENTERED

Other Marks by Molecular Therapeutics

Additional USPTO filings from the same owner.

TRI

TRICIDE

78267999

Molecular Therapeutics

REGISTERED

SIL

SILVAKLENZ

87324050

Molecular Therapeutics

REGISTERED

NEO

NEOCIDE-3

85273331

Molecular Therapeutics

REGISTERED

MOL

MOLECULAR THERAPEUTICS

87323951

Molecular Therapeutics

ABANDONED

Other Marks in Class 035 — Advertising, business management & retail services

Recently filed and registered marks in the same international class.

MOL

MOLECULAR MEDIA

98239437

Molecular Media, Inc.

REGISTERED

MOL

MOLECULAR PERSUASION

97239246

Molecular Persuasion LLC

REGISTERED

MOL

MOLECULAR DEPOT

97430680

MOLECULAR DEPOT LLC

REGISTERED

KEE

KEENOVA THERAPEUTICS

79445783

Mallinckrodt Pharmaceuticals Ireland Limited

REGISTERED

MOLECULAR THERAPEUTICS

Run a conflict check

Other Marks by Molecular Therapeutics

Other Marks in Class 035 — Advertising, business management & retail services

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company